TransMedics appoints Gerardo Hernandez as CFO; updates 2024 revenue guidance to $428M-$432M

TransMedics Group, Inc.

Hernandez appointed CFO effective Dec 2, 2024, succeeding Stephen Gordon, who will remain as non-executive employee through Mar 2025 then senior advisor through Mar 2026.
Hernandez receives $450K base salary, 50% target bonus, and equity awards worth $2M (stock options and RSUs) under the inducement plan.
2024 revenue guidance raised to $428-432M, representing 77-79% year-over-year growth.
Gordon as non-executive employee gets $477K base salary and continues equity vesting; as advisor receives $10K annual fee.
Hernandez brings 25+ years experience, most recently as VP Finance at Alnylam, and previously at Shire/Takeda.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.